Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative drugs operate by mimicking the natural actions of GLP-1, a hormone produced by the gut https://bookmarkpath.com/story20748181/reta-glucagon-like-peptide-1-receptor-agonists